Youth Development Pharmaceutical Association Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 99.26%
- Ebitda 99.26%
- Net Worth -0.85%
- Total Assets -1.67%
About Youth Development Pharmaceutical Association
Youth Development Pharmaceutical Association (YDPA) is a Private Not For Profit Company incorporated in India on 27 May 2020 (Four years and eight months 12 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Education Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Nitinbhai Raval and Jitendra Raval serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U91900GJ2020NPL113679
-
Company No.
113679
-
Company Classification
Private Not For Profit Company
-
Incorporation Date
27 May 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Youth Development Pharmaceutical Association?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nitinbhai Raval
|
Director | 27-May-2020 | Current |
|
Jitendra Raval
|
Director | 27-May-2020 | Current |
Financial Performance of Youth Development Pharmaceutical Association.
Youth Development Pharmaceutical Association, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 99.26% increase in profit. The company's net worth dipped by a decrease of 0.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Youth Development Pharmaceutical Association?
In 2022, Youth Development Pharmaceutical Association had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Brilliant Lifesciences Private LimitedNitinbhai Raval is a mutual person
-
Aatmanirbhar Pharmapark Private LimitedNitinbhai Raval and Jitendra Raval are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Youth Development Pharmaceutical Association?
Youth Development Pharmaceutical Association has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Youth Development Pharmaceutical Association, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Youth Development Pharmaceutical Association's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.